FMK: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
What it covers
A disposable blood lancet intended for a single use that is comprised of a single use blade attached to a solid, non-reusable base (including an integral sharps injury prevention feature) that is used to puncture the skin to obtain a drop of blood for diagnostic purposes. The integral sharps injury prevention feature allows the device to be used once and then renders it inoperable and incapable of further use.
FDA’s definition of product code FMK, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262526 | Safety lancet (XL) | Tianjin Huahong Technology Co., Ltd. | Sep 13, 2026 | Traditional |
| K261045 | Verifine Safety Lancets | Promisemed Hangzhou Meditech Co., Ltd. | May 1, 2026 | Special |
| K260191 | Safety lancet (XXXVII) | Tianjin Huahong Technology Co., Ltd. | Mar 31, 2026 | Traditional |
| K253605 | Safety Heel Lancet | Ningbo Medsun Medical Co., Ltd. | Feb 20, 2026 | Traditional |
| K252490 | Heel Stick Safety Lancet (HHZ-II, HHZ-III, HHZ-IV) | Tianjin Huahong Technology Co., Ltd. | Feb 12, 2026 | Special |
| K251694 | safety lancet | Tianjin Huahong Technology Co., Ltd. | Jun 26, 2025 | Special |
| K244036 | Heel Incision Safety Lancet (SteriHeel 2) | SteriLance Medical (Suzhou), Inc. | Feb 26, 2025 | Traditional |
| K242680 | LetsGetChecked Impress | Privapath Diagnostics Ltd (Dba Letsgetchecked) | Jan 13, 2025 | Traditional |
| K243533 | Sterilized Eol Auto Lancet; Sterilized Eol Lancet Plus | Hlb Co., Ltd. Healthcare | Jan 13, 2025 | Traditional |
| K242664 | gentleheel® Adult Incision Device | Gri-Alleset, Inc. | Nov 5, 2024 | Traditional |
Clearances by year
62 FMK 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 5 | 68 |
| 2025 | 4 | 59 |
| 2024 | 10 | 57 |
| 2023 | 10 | 95 |
| 2022 | 25 | 87 |
| 2021 | 1 | 167 |
| 2019 | 2 | 52 |
| 2017 | 1 | 59 |
| 2016 | 1 | 143 |
| 2013 | 1 | 24 |
| 2012 | 2 | 192 |
Who submits
35 applicants cleared a FMK device since 2011. 48% of the clearances went to applicants in China, then United States (27%), United Kingdom (8%) and Singapore (6%). By type: Traditional 85%, Special 13% and Abbreviated 2%.
| Applicant | Clearances since 2011 |
|---|---|
| Tianjin Huahong Technology Co., Ltd. | 8 |
| Owen Mumford, Ltd. | 5 |
| Promisemed Hangzhou Meditech Co., Ltd. | 5 |
| Ningbo Medsun Medical Co., Ltd. | 4 |
| Roche Diabetes Care, Inc. | 4 |
| SteriLance Medical (Suzhou), Inc. | 4 |
| Gri-Alleset, Inc. | 2 |
| Medipurpose Pte. , Ltd. | 2 |
How FDA classifies it
(b) Single use only blood lancet without an integral sharps injury prevention feature—(1) Identification. A disposable blood lancet intended for a single use that is comprised of a single use blade attached to a solid, non-reusable base that is used to puncture the skin to obtain a drop of blood for diagnostic purposes.
(2) Classification. Class II (special controls). The special controls are:
(i) The design characteristics of the device must ensure that the structure and material composition are consistent with the intended use and address the risk of sharp object injuries and bloodborne pathogen transmissions.
(ii) Mechanical performance testing must demonstrate that the device will withstand forces encountered during use.
(iii) The device must be demonstrated to be biocompatible.
(iv) Sterility testing must demonstrate the sterility of any device component that breaches the skin (e.g., blade).
(v) Labeling must include:
(A) Detailed descriptions, with illustrations, of the proper use of the device.
(B) Handwashing instructions for the user before and after use of the device.
(C) Instructions on preparation (e.g., cleaning, disinfection) of the skin to be pierced.
(D) Instructions for the safe disposal of the device.
(E) Labeling must be appropriate for the intended use environment.
(1) For those devices intended for health care settings, labeling must address the health care facility use of these devices, including how these lancets are to be used with personal protective equipment, such as gloves.
(2) For those devices intended for use in the home, labeling must be written so that it is understandable to lay users.
(vi) Labeling must also include the following statements, prominently placed:
(A) “For use only on a single patient. Discard the entire device after use.”
(B) “Warning: Not intended for more than one use. Do not use on more than one patient. Improper use of blood lancets can increase the risk of inadvertent transmission of bloodborne pathogens, particularly in settings where multiple patients are tested.”
From 21 CFR 878.4850. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 878.4850 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FMK clearances declared.
Ask about FMK
Questions about FMK
What is FDA product code FMK?
Product code FMK, “Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature” in FDA's classification database, is a Class II device type under 21 CFR 878.4850 (blood lancets), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 111 clearances under FMK, 62 of them since 2011.
How many 510(k) clearances are there under FMK?
FDA’s 510(k) database listed 111 clearances under FMK as of Oct 29, 2026, 62 of them decided since 2011; the most recent decision was Sep 13, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a FMK 510(k)?
For the 11 FMK clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 59 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most FMK clearances?
Since 2011: Tianjin Huahong Technology Co., Ltd. (8), Owen Mumford, Ltd. (5), Promisemed Hangzhou Meditech Co., Ltd. (5), Ningbo Medsun Medical Co., Ltd. (4) and Roche Diabetes Care, Inc. (4). 35 applicants have cleared a FMK device in that time.